Skip to content

AtriCure ATRC Total debt

Total debt at other companies

Pulse Biosciences, Inc. logo
Pulse Biosciences, Inc.PLSE
$7.16M-16.6%
ITG
Integer HoldingsITGR
$1.38B+2.0%
Avanos Medical logo
Avanos MedicalAVNS
$138.4M-1.8%
Abbott logo
AbbottABT
Johnson & Johnson logo
Johnson & JohnsonJNJ
Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$141.2M+14.3%
Gross profit$109.3M+18.0%
Operating income$526.0K+109%
Net income$108.0K+102%
EPS (diluted)$0.00+100%

Balance sheet

See full
Cash & equivalents$146.2M+46.3%
Total equity$491.7M+8.2%
Total assets$644.0M+8.8%

Cash flow

See full
Operating cash flow-$4.0M+63.8%
CapEx$3.9M+76.6%
Free cash flow-$7.8M+40.6%

Valuation

See full
Market cap$1.43B-9.9%
Enterprise value$1.36B-13.1%
P/S2.6×-0.7×

Profitability

See full
Gross margin75.6%+0.8pp
Operating margin-5.1%-1.3pp
Net margin-5.6%-1.5pp
FCF margin9.7%

Returns & leverage

See full
Return on equity-6.1%-1.3pp
Debt / equity0.2×0.0×
Current ratio4.3×+0.2×

Where this comes from

Calculated from AtriCure’s reported figures.

Plus components not separately reported this period.

The official record: AtriCure’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about AtriCure's total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AtriCure's total debt?
AtriCure (ATRC) reported total debt of $76.15M in Q1 2026.
How has AtriCure's total debt changed year-over-year?
AtriCure's total debt decreased by 3.1% year-over-year, from $78.63M to $76.15M.
What is the long-term trend for AtriCure's total debt?
Over 5 years (2020 to 2025), AtriCure's total debt has grown at a 1.0% compound annual growth rate (CAGR), from $74M to $77.73M.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.